Hemodialysis-associated hypertension: Pathophysiology and therapy
- 1 February 2002
- journal article
- review article
- Published by Elsevier in American Journal of Kidney Diseases
- Vol. 39 (2) , 227-244
- https://doi.org/10.1053/ajkd.2002.30542
Abstract
No abstract availableKeywords
This publication has 96 references indexed in Scilit:
- Can antihypertensive medications control BP in haemodialysis patients: yes or no?Nephrology Dialysis Transplantation, 1999
- Effects of normal hematocrit on ambulatory blood pressure in epoetin-treated hemodialysis patients with cardiac diseaseKidney International, 1999
- Seasonal Changes in Blood Pressure in Patients with End-Stage Renal Disease Treated with HemodialysisNew England Journal of Medicine, 1998
- Outcome and risk factors for left ventricular disorders in chronic uraemiaNephrology Dialysis Transplantation, 1996
- Impact of hypertension on cardiomyopathy, morbidity and mortality in end-stage renal diseaseKidney International, 1996
- Direct vasopressor effects of erythropoietin in genetically hypertensive ratsLife Sciences, 1993
- Survival as an index of adequacy of dialysisKidney International, 1992
- Direct vasopressor effect of recombinant human erythropoietin on renal resistance vesselsKidney International, 1991
- Impact of left ventricular hypertrophy on survival in end-stage renal diseaseKidney International, 1989
- Correction of the Anemia of End-Stage Renal Disease with Recombinant Human ErythropoietinNew England Journal of Medicine, 1987